Functional foods, neutraceuticals, designer foods: innocent fad or counterproductive marketing ploy? E. Ernst Commentary 05 July 2001 Pages: 353 - 355
Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A-reductase inhibitors (statins) M. IgelT. SudhopK. von Bergmann Review Article 13 July 2001 Pages: 357 - 364
Clinical pharmacology of thalidomide Tommy ErikssonSven BjörkmanPeter Höglund Review Article 13 July 2001 Pages: 365 - 376
Detailed characterization of experimentally derived human hepatic CYP1A1 activity and expression using differential inhibition of ethoxyresorufin O-deethylation by fluvoxamine Sherwin K. SyBing-Kou TangWerner Kalow Pharmacokinetics and Disposition 13 July 2001 Pages: 377 - 386
Pharmacokinetics of salicin after oral administration of a standardised willow bark extract B. SchmidI. KötterL. Heide Pharmacokinetics and Disposition 05 July 2001 Pages: 387 - 391
Pharmacokinetics of cisplatin and relation to nephrotoxicity in paediatric patients Bernhard ErdlenbruchMarit NierMax Lakomek Pharmacokinetics and Disposition 16 June 2001 Pages: 393 - 402
Independent patterns of cytochrome P 450 gene expression in liver and blood in patients with suspected liver disease Niklas FinnströmMari ThörnAnders Rane Pharmacokinetics and Disposition 16 June 2001 Pages: 403 - 409
Pharmacokinetics and pharmacodynamics of epoetin alfa once weekly and three times weekly Wing CheungNeil MintonKulasiri Gunawardena Pharmacokinetics and Disposition 13 July 2001 Pages: 411 - 418
Benzodiazepine use in an elderly community-dwelling population Annie FourrierLuc LetenneurBernard Bégaud Pharmacoepidemiology and Prescription 30 June 2001 Pages: 419 - 425
Levofloxacin-warfarin interaction Giuseppe GhenoLeonardo Cinetto Letter to the Editors 13 July 2001 Pages: 427 - 427
Improving prescribing during pregnancy and puerperium through educational efforts Ana SaboMilan StanulovićZorica Miljković Letter to the Editors 20 July 2001 Pages: 429 - 430